Stewart Fisher
Chief Tech/Sci/R&D Officer bei C4 THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Stewart Fisher is currently the Chief Scientific Officer at C4 Therapeutics, Inc. He previously worked as the Executive Director-Infection Bioscience at AstraZeneca PLC from 1988 to 2013.
Additionally, he held the position of Director-Quantitative, Biochemistry & Enzymology at The Broad Institute, Inc. He also served as the Head-Metabolic Diseases Department at Hoffmann-La Roche, Inc. from 1996 to 1998.
Dr. Fisher holds a doctorate degree from the California Institute of Technology and an undergraduate degree from the University of Vermont.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0,19% | 07.03.2024 | 129 121 ( 0,19% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Stewart Fisher
| Unternehmen | Position | Beginn |
|---|---|---|
| C4 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.05.2018 |
Ehemalige bekannte Positionen von Stewart Fisher
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.08.2013 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.08.1998 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Stewart Fisher
| California Institute of Technology | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
